International Conference on Rare Diseases & Orphan Drug Development

Important dates

1. 17 Dec

   Abstract / full paper deadline

   In 33 days

2. 13–14 Jan

   Conference

   Munich, Germany

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

International Conference on Rare Diseases & Orphan Drug Development ICRDODD, organized by World Research Association for Education and Science, is a leading international conference that connects researchers, engineers, healthcare professionals, academicians, scientists, industry experts, and professionals from around the world. The conference provides a global platform to share groundbreaking research, discuss emerging developments, showcase innovative ideas, and build meaningful professional collaborations. By bringing together diverse academic and professional communities, International Conference on Rare Diseases & Orphan Drug Development ICRDODD aims to promote knowledge exchange, interdisciplinary collaboration, innovation, and the advancement of research on a global scale.

Topics and scope

• Rare Disease Research
• Orphan Drug Development
• Rare Disease Genetics
• Genomic Medicine
• Whole Genome Sequencing
• Exome Sequencing
• Genetic Diagnosis
• Variant Interpretation
• Genotype–Phenotype Correlation
• Rare Disease Biomarkers
• Molecular Diagnostics
• Precision Medicine
• Personalized Therapeutics
• Natural History Studies
• Patient Registries
• Disease Modeling
• Rare Disease Biobanks
• Patient-Derived Models
• Organoid Research
• Drug Target Discovery
• Therapeutic Target Validation
• Small-Molecule Therapies
• Biologic Therapies
• Monoclonal Antibodies
• Enzyme Replacement Therapy
• Gene Therapy
• Genome Editing
• CRISPR Therapeutics
• RNA-Based Therapies
• Antisense Oligonucleotides
• RNA Interference
• mRNA Therapeutics
• Cell Therapy
• Stem Cell Therapy
• Protein Replacement
• Substrate Reduction Therapy
• Drug Repurposing
• Combination Therapies
• Pediatric Rare Diseases
• Rare Neurological Disorders
• Rare Metabolic Diseases
• Rare Genetic Disorders
• Rare Cardiovascular Diseases
• Rare Hematological Diseases
• Rare Immunological Diseases
• Rare Musculoskeletal Diseases
• Rare Ophthalmic Diseases
• Rare Pulmonary Diseases
• Rare Renal Diseases
• Rare Liver Diseases
• Rare Cancers
• Clinical Trial Innovation
• Small-Population Trials
• Adaptive Clinical Trials
• Basket Trials
• Platform Trials
• Bayesian Trial Design
• Surrogate Endpoints
• Digital Biomarkers
• Patient-Reported Outcomes
• Real-World Evidence
• Regulatory Science
• Orphan Drug Designation
• Regulatory Pathways
• Accelerated Drug Development
• Pharmacovigilance
• Post-Marketing Surveillance
• Orphan Drug Economics
• Health Technology Assessment
• Cost-Effectiveness
• Drug Pricing and Access
• Patient-Centered Research
• Patient Advocacy
• Global Rare Disease Policy
• Rare Disease Health Equity
• International Research Collaboration
• AI in Rare Disease Research
• AI-Assisted Diagnosis
• Machine Learning
• Drug Discovery AI
• Multi-Omics Analysis
• Computational Rare Disease Research
• Digital Rare Disease Platforms
• Future of Orphan Medicines

Call for papers

Abstracts are due by 17 December 2026. Submission details are on the official website.